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Past examinations of protein interactions within NRPSs have established the COMD and COMA domains of cognate NRPSs to be
responsible for the selective interactions necessary for proper processing of NRP intermediates. Hur et al. have developed bioor-
thogonal cross-linking probes that are compatible with carrier protein modification and sensitive to the selective protein interactions
of the COM domains between cognate NRPSs. Based on these results, the authors aim to apply these tools towards structural
studies of the interactions that occur during selective communication between NRPS modules and to gain further insight into the
cryptic mechanisms employed by multifunctional biosynthetic assembly lines.Ion Mobility to the RescueChemistry & BioPAGE 382
Frequently, subtle differences in the stability afforded by
ligand binding to protein assemblies cannot be detected by
mass spectrometry (MS). Here, Hyung et al. show that moni-
toring the unfolding of protein subunits, using ionmobility-MS
(IM-MS), allows differentiation of the effects of ligand binding
not normally observed by MS alone. Using wild-type and
disease-associated variants of tetrameric transthyretin, MS
data indicate that populations of the variant protein are less
stable than wild type. IM-MS, however, is able to show that
the natural ligand of transthyretin, thyroxine, provides a larger
stability increase to the tetramer composed of variant
subunits than to the wild-type protein-ligand complex.Oncogene Fighting Peptides
PAGE 391
Rho GTPases are activated by RhoGEFs, many of which have been isolated as oncogenes. Strategies to inhibit their activity are
therefore actively being sought. Here Bouquier et al. devise a peptide inhibitor screening strategy to target the activity of the onco-
genic RhoGEF Tgat. Using this strategy, the authors identify a peptide that specifically inhibits Tgat GEF activity in vitro and strongly
reduces its oncogenic properties in vivo, most remarkably by decreasing tumor development in nude mice. They demonstrate that
small peptides are potent inhibitors that can interfere with RhoGEF functions in vivo, which represents a promising alternative for the
discovery of leads for new therapeutic drugs.N-methyltransferase MtfA for Modifying Glycopeptide Antibiotics
PAGE 401
Glycopeptide antibiotics (GPAs) comprise a class of anti-infective agents with activity
against seriousGram-positivebacterial pathogens.However, resistance to theseantibiotics
is becoming a serious and growing threat. Shi et al. have shown that the N-methyltransfer-
ase MtfA from the vancomycin-class GPA biosynthetic pathway can be used in vitro and
in vivo to expand the chemical diversity of teicoplanin-like GPAs by additional methylation
of the peptide scaffold. The crystal structure of MtfA together with computational docking
and molecular dynamics simulations provided a model of demethyl-vancomycin aglycone
binding to MtfA. Enzyme-catalyzed methyl transfer can be explored as another approach
to generate methylated GPA derivatives. (Figure credit: Shi et al.)Making Pain Go Away
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Endocannabinoids are lipid signaling molecules that regulate a wide range of mammalian
behaviors, including pain, inflammation, and cognitive/emotional state. The endocannabi-
noid anandamide is principally degraded by the integral membrane enzyme fatty acid
amide hydrolase (FAAH), and there is currently much interest in developing FAAH inhibitors
to augment endocannabinoid signaling in vivo. Here Ahn et al. report the discovery of an
FAAH inhibitor PF-3845 that displays an unprecedented combination of potency, selectivity, and in vivo efficacy. PF-3845 selectively
inhibits FAAH in vivo, raises brain anandamide levels for up to 24 hr, and produces profound cannabinoid-receptor-dependent
reductions in inflammatory pain.logy 16, April 24, 2009 ª2009 Elsevier Ltd All rights reserved ix
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Pyrrole-amide antibiotics are DNA minor-groove binders. Juguet et al. report characterization of a gene cluster directing the biosyn-
thesis of a pyrrole-amide antibiotic, congocidine (netropsin), from S. ambofaciens that was previously uncharacterized. They show
that congocidine is assembled by an iterative nonribosomal peptide synthetase (NRPS) constituted of a free-standing module and
several single-domain proteins and propose an assembly mechanism that provides a basis for the elucidation of the molecular
principles of the biosynthesis of antibiotics of the pyrrole-amide family. Both the atypical organization and the mechanism of the
NRPS illustrate the versatility of this family of enzymes.Genetic Screen in Reverse and Chemicalx Chemistry & Biology 16, April 24, 2009PAGE 432
Inhibition of blood vessel growth in a tumor is an important mode of action for several
oncology drugs used in clinical practice. However, new drugs are needed as existing ones
are hampered by limited efficacy and side effects. Kale´n et al. combined two different
screening approaches, reverse- and chemical genetic screening, and identified 16 putative
drug targets and 28 pharmacologically active compounds regulating blood vessel growth
and function. Importantly, the study suggests that drug targets and compounds for complex
biological processes, such as blood vessel growth, can be efficiently identified through
combination of vertebrate screening models. (Figure from Kale´n et al.)ssDNA Aptamer Meets Serine Protease
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Activated protein C (APC) is a serine protease that plays a central role in the regulation of the hemostatic network and possesses
anti-inflammatory and cytoprotective functions. Now, Mu¨ller et al. describe results of selection of a class of high-affinity ssDNA
APC-aptamers (HS02) that selectively inhibit the anticoagulant activity of APC without affecting its cytoprotective functions. The
ability to specifically inhibit APC’s anticoagulant functionsmakes HS02 a potential therapeutic agent for the treatment of APC-related
bleeding. Finally, the exosite specificity of the APC aptamersmakes them interestingmolecular tools to probe APC’s interactions with
several macromolecular substrates and cellular receptors.Androgen Receptor Presents Its Surfaces
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Different nuclear receptors (NR) ligands exert different effects on NR structure, which leads to differential presentation of protein-
protein interaction surfaces on NRs and binding of functionally distinct interaction partners. Norris et al. focus on androgen receptor
(AR) to develop an approach to link ligand-induced changes in receptor structure to specific pharmacological responses by identi-
fying over 150 proteins/polypeptides that interact with AR in a manner differentially affected by ligand binding. The accumulated
information on protein-AR interactions was employed to develop a compound-profiling tool for separating ligands into functionally
distinguishable classes.DF508 CFTR Escapes Doom, SGC Mimics
Implicated
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The glycosphingolipid, sulfogalactosyl ceramide (SGC) binds the N-terminal domain
of all Hsp70s to inhibit the ATPase activity required for peptide binding and chaperone
function. Park et al. test the effect of a soluble SGC mimic on Hsp70 chaperone-
dependent, endoplasmic reticulum-associated degradation (ERAD) of misfolded
DF508 cystic fibrosis transmembrane conductance regulator (DF508CFTR), an impor-
tant factor in cystic fibrosis. AdamantylSGC reduced DF508CFTR ERAD, suggesting
inhibition of Hsp70 chaperone function in cells. ERAD blockade alone was, however,
insufficient for maturation of rescued DF508CFTR. The lower SGC level of cells and
tissues defective in CFTR indicates a role in SGC synthesis and implies a potential
‘‘catch 22’’ cycle to promote DF508CFTR degradation.ª2009 Elsevier Ltd All rights reserved
